Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R G Kilbourn

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Critical Care Medicine|September 20, 1997
Nitric oxide overproduction in septic shock--methemoglobin concentrations and blockade with diaspirin cross-linked hemoglobinR G Kilbourn
Research in Immunology|September 1, 1991
Regulation of nitric oxide biosynthesis: cofactor requirement and enzymatic characteristicsR G Kilbourn
Molecular Medicine Today|August 1, 1996
Nitric oxide: moving towards the clinicR G Kilbourn
Journal of the National Cancer Institute|May 2, 1990
Endothelial cell production of nitrogen oxides in response to interferon gamma in combination with tumor necrosis factor, interleukin-1, or endotoxinR G Kilbourn, P Belloni
Cancer Metastasis Reviews|April 17, 1998
The role of nitric oxide in interleukin-2 therapy induced hypotensionH Shahidi, R G Kilbourn
Journal of the National Cancer Institute|November 4, 1992
Inhibition of inducible nitric oxide synthase with inhibitors of tetrahydrobiopterin biosynthesisR G Kilbourn, O W Griffith
Journal of the National Cancer Institute|June 3, 1992
Overproduction of nitric oxide in cytokine-mediated and septic shockR G Kilbourn, O W Griffith
Methods in Enzymology|January 1, 1996
Nitric oxide synthase inhibitors: amino acidsO W Griffith, R G Kilbourn
Critical Care Medicine|December 1, 1999
Can nitric oxide production be modulated by altering L-arginine levels?R G Kilbourn, R D Goldfarb
Advances in Enzyme Regulation|January 1, 1997
Design of nitric oxide synthase inhibitors and their use to reverse hypotension associated with cancer immunotherapyO W Griffith, R G Kilbourn
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Critical Care Medicine|September 20, 1997
Nitric oxide overproduction in septic shock--methemoglobin concentrations and blockade with diaspirin cross-linked hemoglobinR G Kilbourn
Research in Immunology|September 1, 1991
Regulation of nitric oxide biosynthesis: cofactor requirement and enzymatic characteristicsR G Kilbourn
Molecular Medicine Today|August 1, 1996
Nitric oxide: moving towards the clinicR G Kilbourn
Journal of the National Cancer Institute|May 2, 1990
Endothelial cell production of nitrogen oxides in response to interferon gamma in combination with tumor necrosis factor, interleukin-1, or endotoxinR G Kilbourn, P Belloni
Cancer Metastasis Reviews|April 17, 1998
The role of nitric oxide in interleukin-2 therapy induced hypotensionH Shahidi, R G Kilbourn
Journal of the National Cancer Institute|November 4, 1992
Inhibition of inducible nitric oxide synthase with inhibitors of tetrahydrobiopterin biosynthesisR G Kilbourn, O W Griffith
Journal of the National Cancer Institute|June 3, 1992
Overproduction of nitric oxide in cytokine-mediated and septic shockR G Kilbourn, O W Griffith
Methods in Enzymology|January 1, 1996
Nitric oxide synthase inhibitors: amino acidsO W Griffith, R G Kilbourn
Critical Care Medicine|December 1, 1999
Can nitric oxide production be modulated by altering L-arginine levels?R G Kilbourn, R D Goldfarb
Advances in Enzyme Regulation|January 1, 1997
Design of nitric oxide synthase inhibitors and their use to reverse hypotension associated with cancer immunotherapyO W Griffith, R G Kilbourn
Pageof 5